Literature DB >> 32529319

Past appendectomy may be related to early cognitive dysfunction in Parkinson's disease.

Alexandra R Gonçalves1,2, Alexandre Mendes3,4, Nuno Vila-Chã3,5, Joana Damásio3,6, Joana Fernandes7, Sara M Cavaco3,4.   

Abstract

INTRODUCTION: The vermiform appendix is a potential site of initiation of Parkinson's disease (PD) pathology. We hypothesized that the appendectomy earlier in life may alter the clinical expression of PD.
OBJECTIVE: To explore the effects of appendectomy prior to onset of PD motor symptoms on patients' symptoms, in particular on cognitive dysfunction.
METHODS: Two hundred and sixty-two consecutive PD patients were asked about past history of appendectomy and underwent an evaluation, which included the Unified Parkinson's Disease Rating Scale (UPDRS), Hoehn & Yahr scale (H&Y), Schwab & England Independence Scale (S&E), Dementia Rating Scale-2 (DRS-2), Apathy Evaluation Scale, Hospital Anxiety and Depression Scale, and Brief Smell Identification Test. Motor symptoms were evaluated in OFF and ON states. Non-parametric group comparisons and logistic regressions were used for data analyses.
RESULTS: Thirty-one patients (11.8%) had history of appendectomy prior to PD onset. These patients had more severe motor symptoms (UPDRS-III and H&Y) and lower functional independence (S&E) in ON and had higher frequency of cognitive dysfunction (DRS-2 Initiation/Perseveration, Conceptualization, and Memory subscales) (p < 0.05). The association between history of appendectomy and cognitive dysfunction was evident only in patients with late onset PD (≥ 55 years) and with disease duration ≤ 5 years. History of appendectomy remained statistically associated with impairment on DRS-2 Conceptualization and Memory subscales, when demographic and clinical variables were considered.
CONCLUSION: History of appendectomy appears to alter the clinical expression of late onset PD, with early cognitive impairment, more severe motor symptoms in ON, and poorer functional independence under anti-parkinsonian medication.

Entities:  

Keywords:  Appendectomy; Cognitive dysfunction; Parkinson’s disease

Mesh:

Year:  2020        PMID: 32529319     DOI: 10.1007/s10072-020-04507-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  39 in total

1.  Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease.

Authors:  H I Hurtig; J Q Trojanowski; J Galvin; D Ewbank; M L Schmidt; V M Lee; C M Clark; G Glosser; M B Stern; S M Gollomp; S E Arnold
Journal:  Neurology       Date:  2000-05-23       Impact factor: 9.910

2.  Memory and executive function impairment predict dementia in Parkinson's disease.

Authors:  Gilberto Levy; Diane M Jacobs; Ming-Xin Tang; Lucien J Côté; Elan D Louis; Brenda Alfaro; Helen Mejia; Yaakov Stern; Karen Marder
Journal:  Mov Disord       Date:  2002-11       Impact factor: 10.338

Review 3.  Milestones in Parkinson's disease--clinical and pathologic features.

Authors:  Glenda Halliday; Andrew Lees; Matthew Stern
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

Review 4.  The neurobiological basis of cognitive impairment in Parkinson's disease.

Authors:  Glenda M Halliday; James B Leverenz; Jay S Schneider; Charles H Adler
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

5.  Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.

Authors:  P M Mattila; J O Rinne; H Helenius; D W Dickson; M Röyttä
Journal:  Acta Neuropathol       Date:  2000-09       Impact factor: 17.088

6.  Cognitive status correlates with neuropathologic stage in Parkinson disease.

Authors:  H Braak; U Rüb; E N H Jansen Steur; K Del Tredici; R A I de Vos
Journal:  Neurology       Date:  2005-04-26       Impact factor: 9.910

7.  Neuropathologic substrates of Parkinson disease dementia.

Authors:  David J Irwin; Matthew T White; Jon B Toledo; Sharon X Xie; John L Robinson; Vivianna Van Deerlin; Virginia M-Y Lee; James B Leverenz; Thomas J Montine; John E Duda; Howard I Hurtig; John Q Trojanowski
Journal:  Ann Neurol       Date:  2012-10-04       Impact factor: 10.422

8.  The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years.

Authors:  Mariese A Hely; Wayne G J Reid; Michael A Adena; Glenda M Halliday; John G L Morris
Journal:  Mov Disord       Date:  2008-04-30       Impact factor: 10.338

9.  Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

Authors:  Yaroslau Compta; Laura Parkkinen; Sean S O'Sullivan; Jana Vandrovcova; Janice L Holton; Catherine Collins; Tammaryn Lashley; Constantinos Kallis; David R Williams; Rohan de Silva; Andrew J Lees; Tamas Revesz
Journal:  Brain       Date:  2011-05       Impact factor: 13.501

10.  Differences in neuropathologic characteristics across the Lewy body dementia spectrum.

Authors:  C Ballard; I Ziabreva; R Perry; J P Larsen; J O'Brien; I McKeith; E Perry; D Aarsland
Journal:  Neurology       Date:  2006-12-12       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.